SG Americas Securities’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.57M Sell
100,278
-18,826
-16% -$443K ﹤0.01% 1384
2026
Q1
$1.78M Sell
119,104
-864,326
-88% -$14.7M ﹤0.01% 1454
2025
Q4
$14.3M Buy
983,430
+965,773
+5,470% +$16.8M 0.02% 621
2025
Q3
$317K Sell
17,657
-2,113
-11% -$31K ﹤0.01% 2447
2025
Q2
$337K Sell
19,770
-28,169
-59% -$282K ﹤0.01% 1919
2025
Q1
$347K Buy
+47,939
New +$546K ﹤0.01% 2085
2024
Q4
Sell
-9,701
Closed -$115K 3214
2024
Q3
$115K Sell
9,701
-182,938
-95% -$1.9M ﹤0.01% 2955
2024
Q2
$1.79M Buy
+192,639
New +$984K 0.01% 1012

Other funds holding CORZ

SG Americas Securities's CORZ Position: Q2 2026 in Review

SG Americas Securities reduced its Core Scientific (CORZ) stake by 16% in Q2 2026, selling an estimated $443K and leaving 100,278 shares worth $2.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1384.

SG Americas Securities first reported a position in CORZ in Q2 2024 and has held it in 8 quarters since. The position peaked at $14.3M in Q4 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • SG Americas Securities held 100,278 shares of Core Scientific worth $2.57M as of Q2 2026.
  • SG Americas Securities sold 18,826 Core Scientific shares in Q2 2026, an estimated $443K.
  • Core Scientific made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1384 holding.
  • SG Americas Securities first reported a position in Core Scientific in Q2 2024 and has held it in 8 quarters since.
  • SG Americas Securities's Core Scientific position peaked at $14.3M in Q4 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.